• Something wrong with this record ?

Long-Term Cognitive Decline in Dementia with Lewy Bodies in a Large Multicenter, International Cohort

MG. Kramberger, B. Auestad, S. Garcia-Ptacek, C. Abdelnour, JG. Olmo, Z. Walker, AW. Lemstra, E. Londos, F. Blanc, L. Bonanni, I. McKeith, B. Winblad, FJ. de Jong, F. Nobili, E. Stefanova, M. Petrova, C. Falup-Pecurariu, I. Rektorova, S....

. 2017 ; 57 (3) : 787-795.

Language English Country Netherlands

Document type Journal Article, Multicenter Study

BACKGROUND/OBJECTIVE: The aim of this study was to describe the rate and clinical predictors of cognitive decline in dementia with Lewy bodies (DLB), and compare the findings with Alzheimer's disease (AD) and Parkinson's disease dementia (PDD) patients. METHODS: Longitudinal scores for the Mini-Mental State Examination (MMSE) in 1,290 patients (835 DLB, 198 PDD, and 257 AD) were available from 18 centers with up to three years longitudinal data. Linear mixed effects analyses with appropriate covariates were used to model MMSE decline over time. Several subgroup analyses were performed, defined by anti-dementia medication use, baseline MMSE score, and DLB core features. RESULTS: The mean annual decline in MMSE score was 2.1 points in DLB, compared to 1.6 in AD (p = 0.07 compared to DLB) and 1.8 in PDD (p = 0.19). Rates of decline were significantly higher in DLB compared to AD and PDD when baseline MMSE score was included as a covariate, and when only those DLB patients with an abnormal dopamine transporter SPECT scan were included. Decline was not predicted by sex, baseline MMSE score, or presence of specific DLB core features. CONCLUSIONS: The average annual decline in MMSE score in DLB is approximately two points. Although in the overall analyses there were no differences in the rate of decline between the three neurodegenerative disorders, there were indications of a more rapid decline in DLB than in AD and PDD. Further studies are needed to understand the predictors and mechanisms of cognitive decline in DLB.

3rd Department of Neurology Medical School Aristotle University of Thessaloniki Greece

Brain and Mind Research Program Central European Institute of Technology Central European Institute of Technology Masaryk University Masaryk University Brno Czech Republic

Center for Parkinson's disease and Movement Disorder Fondazione Ospedale San Camillo Istituto di Ricovero e Cura a Carattere Scientifico Venice Lido Italy

Clinical Memory Research Unit Department of Clinical Sciences Department of Neuroscience and Imaging and Aging Research Centre G d'Annunzio University Chieti Italy

Clinical Memory Research Unit Department of Clinical Sciences Lund University Malmö Sweden

Clinical Neurology Department of Neuroscience University of Genoa Italy

Department of Neurobiology Care Sciences and Society Center for Alzheimer Research Division of Clinical Geriatrics Karolinska Institutet Stockholm Sweden Department of Geriatric Medicine Karolinska University Hospital Huddinge Stockholm Sweden

Department of Neurobiology Care Sciences and Society Division of Neurogeriatrics Karolinska Institutet Stockholm Sweden

Department of Neurobiology Care Sciences and Society Division of Neurogeriatrics Karolinska Institutet Stockholm Sweden Institute of Psychiatry Psychology and Neuroscience King's College London UK Center for Age Related Medicine Stavanger University Hospital Stavanger Norway

Department of Neurology and Alzheimer Centre VU University Medical Centre Amsterdam The Netherlands

Department of Neurology County Emergency Clinic Hospital Faculty of Medicine Transilvania University Brasov Romania

Department of Neurology University Medical Centre Ljubljana Slovenia Department of Neurobiology Care Sciences and Society Division of Neurogeriatrics Karolinska Institutet Stockholm Sweden

Department of Psychiatry University of Cambridge School of Clinical Medicine Cambridge UK

Departments of Psychiatry and Neurology Perelman School of Medicine at the University of Pennsylvania Philadelphia Pennsylvania USA

Division of Psychiatry University College London and North Essex Partnership University NHS Foundation Trust UK

Erasmus MC University Medical Center Rotterdam The Netherlands

Fundació ACE Institut Català de Neurociències Aplicades Barcelona Spain

Girona Biomedical Research Institute Girona Spain

Institute of Neurology CCS School of Medicine University of Belgrade Belgrade Serbia

Research Department Stavanger University Hospital and Department of Mathematics and Natural Sciences The University of Stavanger Stavanger Norway

Service of Neurology and Geriatrics University Hospital of Strasbourg and Icube laboratory University of Strasbourg France

University Hospital Alexandrovska Department of Neurology Sofia Bulgaria

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17030955
003      
CZ-PrNML
005      
20181114065522.0
007      
ta
008      
171025s2017 ne f 000 0|eng||
009      
AR
024    7_
$a 10.3233/JAD-161109 $2 doi
035    __
$a (PubMed)28304294
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Kramberger, Milica G $u Department of Neurology, University Medical Centre, Ljubljana, Slovenia. Department of Neurobiology, Care Sciences and Society, Division of Neurogeriatrics, Karolinska Institutet, Stockholm, Sweden.
245    10
$a Long-Term Cognitive Decline in Dementia with Lewy Bodies in a Large Multicenter, International Cohort / $c MG. Kramberger, B. Auestad, S. Garcia-Ptacek, C. Abdelnour, JG. Olmo, Z. Walker, AW. Lemstra, E. Londos, F. Blanc, L. Bonanni, I. McKeith, B. Winblad, FJ. de Jong, F. Nobili, E. Stefanova, M. Petrova, C. Falup-Pecurariu, I. Rektorova, S. Bostantjopoulou, R. Biundo, D. Weintraub, D. Aarsland, . ,
520    9_
$a BACKGROUND/OBJECTIVE: The aim of this study was to describe the rate and clinical predictors of cognitive decline in dementia with Lewy bodies (DLB), and compare the findings with Alzheimer's disease (AD) and Parkinson's disease dementia (PDD) patients. METHODS: Longitudinal scores for the Mini-Mental State Examination (MMSE) in 1,290 patients (835 DLB, 198 PDD, and 257 AD) were available from 18 centers with up to three years longitudinal data. Linear mixed effects analyses with appropriate covariates were used to model MMSE decline over time. Several subgroup analyses were performed, defined by anti-dementia medication use, baseline MMSE score, and DLB core features. RESULTS: The mean annual decline in MMSE score was 2.1 points in DLB, compared to 1.6 in AD (p = 0.07 compared to DLB) and 1.8 in PDD (p = 0.19). Rates of decline were significantly higher in DLB compared to AD and PDD when baseline MMSE score was included as a covariate, and when only those DLB patients with an abnormal dopamine transporter SPECT scan were included. Decline was not predicted by sex, baseline MMSE score, or presence of specific DLB core features. CONCLUSIONS: The average annual decline in MMSE score in DLB is approximately two points. Although in the overall analyses there were no differences in the rate of decline between the three neurodegenerative disorders, there were indications of a more rapid decline in DLB than in AD and PDD. Further studies are needed to understand the predictors and mechanisms of cognitive decline in DLB.
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a analýza rozptylu $7 D000704
650    _2
$a kognitivní poruchy $x diagnóza $x etiologie $7 D003072
650    _2
$a kohortové studie $7 D015331
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mezinárodní spolupráce $7 D007391
650    _2
$a demence s Lewyho tělísky $x komplikace $x diagnóza $7 D020961
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a záznam o duševním stavu $7 D008609
650    _2
$a lidé středního věku $7 D008875
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
700    1_
$a Auestad, Bjørn $u Research Department, Stavanger University Hospital and Department of Mathematics and Natural Sciences, The University of Stavanger, Stavanger, Norway. $7 gn_A_00009993
700    1_
$a Garcia-Ptacek, Sara $u Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Division of Clinical Geriatrics, Karolinska Institutet, Stockholm, Sweden. Department of Geriatric Medicine, Karolinska University Hospital Huddinge, Stockholm, Sweden.
700    1_
$a Abdelnour, Carla $u Fundació ACE Institut Català de Neurociències Aplicades, Barcelona, Spain. $7 gn_A_00000362
700    1_
$a Olmo, Josep Garre $u Girona Biomedical Research Institute, Girona, Spain.
700    1_
$a Walker, Zuzana $u Division of Psychiatry, University College London and North Essex Partnership University NHS Foundation Trust, UK.
700    1_
$a Lemstra, Afina W $u Department of Neurology and Alzheimer Centre, VU University Medical Centre, Amsterdam, The Netherlands.
700    1_
$a Londos, Elisabet $u Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Malmö, Sweden.
700    1_
$a Blanc, Frederic $u Service of Neurology and Geriatrics, University Hospital of Strasbourg and Icube laboratory, University of Strasbourg, France.
700    1_
$a Bonanni, Laura $u Clinical Memory Research Unit, Department of Clinical Sciences, Department of Neuroscience and Imaging and Aging Research Centre, G. d'Annunzio University, Chieti, Italy.
700    1_
$a McKeith, I. G. $u Department of Psychiatry, University of Cambridge School of Clinical Medicine, Cambridge, UK. $7 xx0229366
700    1_
$a Winblad, Bengt $u Department of Neurobiology, Care Sciences and Society, Division of Neurogeriatrics, Karolinska Institutet, Stockholm, Sweden.
700    1_
$a de Jong, Frank Jan $u Erasmus MC - University Medical Center, Rotterdam, The Netherlands.
700    1_
$a Nobili, Flavio $u Clinical Neurology, Department of Neuroscience (DINOGMI), University of Genoa, Italy.
700    1_
$a Stefanova, Elka $u Institute of Neurology CCS, School of Medicine, University of Belgrade, Belgrade, Serbia.
700    1_
$a Petrova, Maria $u University Hospital "Alexandrovska", Department of Neurology, Sofia, Bulgaria.
700    1_
$a Falup-Pecurariu, Cristian $u Department of Neurology, County Emergency Clinic Hospital, Faculty of Medicine, Transilvania University, Brasov, Romania.
700    1_
$a Rektorova, Irena $u Brain and Mind Research Program, Central European Institute of Technology, Central European Institute of Technology Masaryk University, Masaryk University, Brno, Czech Republic.
700    1_
$a Bostantjopoulou, Sevasti $u 3rd Department of Neurology, Medical School, Aristotle University of Thessaloniki, Greece.
700    1_
$a Biundo, Roberta $u Center for Parkinson's disease and Movement Disorder "Fondazione Ospedale San Camillo" - Istituto di Ricovero e Cura a Carattere Scientifico, Venice-Lido, Italy.
700    1_
$a Weintraub, Daniel $u Departments of Psychiatry and Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
700    1_
$a Aarsland, Dag $u Department of Neurobiology, Care Sciences and Society, Division of Neurogeriatrics, Karolinska Institutet, Stockholm, Sweden. Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK. Center for Age-Related Medicine, Stavanger University Hospital, Stavanger, Norway. $7 gn_A_00000109
700    1_
$a ,
773    0_
$w MED00006350 $t Journal of Alzheimer's disease JAD $x 1875-8908 $g Roč. 57, č. 3 (2017), s. 787-795
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28304294 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20171025 $b ABA008
991    __
$a 20181114065608 $b ABA008
999    __
$a ok $b bmc $g 1254548 $s 991982
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 57 $c 3 $d 787-795 $i 1875-8908 $m Journal of Alzheimer's disease $n J Alzheimers Dis $x MED00006350
LZP    __
$a Pubmed-20171025

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...